Nigel Crossland argues that we need to revisit manufacturer advice and approaches to insulin, particularly with temperatures increasing.
During the summer months of 2022 much of Europe was exposed to above normal temperatures. For several weeks, temperatures were peaking at well above 35°C and on occasions reaching 40°C in the UK. In the absence of air conditioning, indoor temperatures were similar. We tend to think that it’s only old technology that cannot cope with hot weather in the summer, such as buckling rail lines, assuming that all aspects of modern life are better. But are we correct to allow ourselves to think like this, especially when considering systems such as healthcare where medicines for example need very careful thermal protection, as in the case of vaccines?
Click here to read the full article.
Image credit | iStock
